Generics News
-
Australia-based Mayne Pharma sells US generic prescription product portfolio for $90 M
Generics | News | 0 Comment | 28 Feb, 2023
Dr. Reddy's Laboratories SA, a wholly-owned subsidiary of Indian pharmaceutical company Dr. Reddy’s Laboratories, ...Read more
-
Indian pharma firm Venus Remedies gets marketing approval for cancer drugs in Uzbekistan, Palestine
Generics | News | 0 Comment | 23 Feb, 2023
Indian pharmaceutical company Venus Remedies has received marketing authorisation for its generic cancer drugs from Uzbe...Read more
-
ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist
Generics | News | 0 Comment | 28 Sep, 2022
Trans-Atlantic private equity healthcare specialist ArchiMed has invested in Bielefeld, Germany-based PlasmidFactory. Fo...Read more
-
Generics | News | 0 Comment | 08 Aug, 2022
Pharmaceutical companies need to ensure they have a competitive edge in the market while adapting to evolving industry b...Read more
-
35 manufacturers sign agreements to produce generic versions of Pfizer's oral COVID-19 drug
Generics | News | 0 Comment | 18 Mar, 2022
The Medicines Patent Pool (MPP) has signed agreements with 35 companies to manufacture the generic version of Pfizer's o...Read more
-
Taiwan approves new first-line treatment for advanced renal cell carcinoma
Generics | News | 0 Comment | 31 Jan, 2022
Eisai Co. has announced that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inh...Read more
-
Eisai to market Gilead’s rheumatoid arthritis drug in Asia
Generics | News | 0 Comment | 23 Dec, 2021
Japanese firm Eisai has entered into an agreement with Gilead Sciences, Inc. for the commercialisation and distribution ...Read more
-
Biocon partners with Tabuk Pharma to commercialise speciality generic medicines in Middle East
Generics | News | 0 Comment | 08 Dec, 2021
Indian firm Biocon has announced a partnership with Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary...Read more
-
C2 PHARMA Completes Multiple Local Regulatory Filings and Expands Portfolio
Generics | News | 0 Comment | 10 Nov, 2021
Multiple regulatory filings have been submitted to expand distribution channels globally across China, Taiwan, South Kor...Read more
-
Patient access to gene therapies for cancer set to increase in next decade: GlobalData
Generics | News | 0 Comment | 25 Jun, 2021
Gene therapies will provide a valid treatment option for patients that have developed resistance to chemotherapies acros...Read more
-
Bayer leads Metagenomi complete $65M series A financing round
Generics | News | 0 Comment | 16 Nov, 2020
US-based Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully com...Read more
-
Cells for Cells and Austrianova announce publication on novel method to produce stem cell exosomes
Generics | News | 0 Comment | 21 May, 2020
These EVs are known to mediate many of the therapeutic effects of stem cells. The authors show that Austrianova’s ...Read more
-
Indian Pharma market to raise from US$34.3bn in 2020 to more than US$45bn by 2025
Generics | News | 0 Comment | 24 Feb, 2020
Following the recent news that Dr Reddy's Laboratories (DRL) has agreed to acquire Wockhardt Ltd’s select division...Read more
-
Towa to acquire Esteve’s generic division for 320M euros
Generics | News | 0 Comment | 24 Dec, 2019
Japan based TOWA PHARMACEUTICAL CO., LTD. and Spain based pharma company ESTEVE have announced that TOWA will acquire 10...Read more
-
Panacea Biotec launches diabetes drug in India
Generics | News | 0 Comment | 11 Dec, 2019
Panacea Biotec is pleased to announce launch of brand ViLACT in India. ViLACT is used in the treatment of Uncontrolled T...Read more
-
HEC Pharm, Biocon, Sun Pharma get FDA approval for MS drug
Generics | News | 2 Comment | 06 Dec, 2019
The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsule...Read more
-
Eris Lifesciences acquires trademark Zomelis from Novartis for India market
Generics | News | 0 Comment | 04 Dec, 2019
Eris Lifesciences has announced the acquisition of the trademark Zomelis (for Vildagliptin based formulations)...Read more
-
EMA and FDA accept marketing applications for Chugai's Satralizumab
Generics | News | 0 Comment | 31 Oct, 2019
Chugai Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Ap...Read more
